HYDROmorphone Risk Reduction

HOME

PATIENT SAFETY AUTHORITY

PA-PSRS and PASSKEY

PATIENT SAFETY ADVISORIES

PATIENTS AND CONSUMERS

NEWS AND INFORMATION

EDUCATIONAL TOOLS

AUTHORITY EVENTS

ADDRESS:
Patient Safety Authority
333 Market Street
Lobby Level
Harrisburg, PA 17120

Phone: 717-346-0469
Fax: 717-346-1090

Advanced Search

HYDROmorphone Risk Reduction

	Healthcare facilities can strive to identify system-based causes of wrong drug and wrong dose/overdose errors with the use of HYDROmorphone and other opioids. Risk reduction strategies such as constraints and standardization, which focus on system improvement, will be more effective than education alone, which relies on individual performance.

Prevention Program Tools	Articles
Educational Tools

In response to medication errors reported to the U.S. Food and Drug Administration (FDA), the Institute for Safe Medication Practices, the Authority, and other reporting programs, FDA has approved labeling revisions to HYDROmorphone products to prevent associated medication errors.

Adverse Drug Events with HYDROmorphone: How Preventable are They?

Gaps exist in healthcare providers’ understanding of the efficacy and potency of HYDROmorphone, as evidenced by medication errors and adverse drug reactions reported in Pennsylvania.

Inadvertent Mix-Up of Morphine and Hydromorphone: A Potent Error

Hydromorphone is a common alternative to morphine; however, hydromorphone’s analgesic equivalence must be considered because it is more potent than morphine when administered by any route.

Browse by Topic

	Discipline
	Audience
	Care Setting
	Event
	Patient Safety Focus
	Hospital-Acquired Condition

Prevention Program Tools

Educational Tools

Articles